How GlaxoSmithKline chief has changed the agenda for big pharma - ? Shift in expectations over health in developing world ? Critics say GSK hopes for profits in future years Few who hear him doubt Andrew Witty's desire to improve health in the developing world is sincere. But critics of GlaxoSmithKline's chief executive point out that his moves to reduce the price of medicine in poor countries have cost Britain's biggest drug company little, and that there m... [AIDSPORTAL.org]